The Keosys Blog

Expert insights into medical imaging in clinical trials.
Evaluating Tumor Response in HCC
This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..
An Interventional Radiologist Talks About Radioembolization in the Treatment of HCC Today
Dr. Yan Rolland, head of the diagnosis and interventional radiology department..
A Radiology Professor Talks About mRECIST, Reading Images in Clinical Trials, and More
Maxime Ronot, Professor at the Université de Paris, and Radiologist in the..
Interview: Keosys Advances into a Promising New Year
With our 20th anniversary year recently completed and a new year underway, we..
Case Study - Setting up a Project in a Short Turnaround Time
Sometimes sponsors and CROs are not sure in the early stages of a trial that..
Modified Recist for HCC with Infographic
  mRECIST was developed in 2010 to adapt RECIST v1.1 to the particularities of..
Questions to Ask Yourself About Imaging in Clinical Trials
Starting a trial can be very challenging. There are many actors involved and..
5 Myths About Imaging CROs
In the race against COVID, clinical trials regularly made the headlines. People..
How to Prepare an Imaging Study While Minimizing Budget and Risk
Sometimes sponsors and CROs are not sure in the early stages of a trial that..
Automatic Quantification of Background Activity in the PERCIST Criteria
Positron Emission tomography Response Criteria In Solid Tumors (PERCIST) allows..
Photography as Imaging in Dermato-Oncology Clinical Trials
The health industry has been impacted by numerous technological advances in..

More Posts

New call-to-action